Rs 132.5 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Vogli 0.2 mg Tablets are specifically designed to address symptoms related to vestibular disorders and Meniere's disease. Each tablet contains 0.2 mg of Betahistine dihydrochloride, a medication known for its efficacy in reducing dizziness, vertigo, and tinnitus by improving blood flow to the inner ear. This enhancement in circulation helps to stabilize inner ear pressure and alleviate the associated symptoms. The tablet form ensures ease of use and accurate dosing, making it a practical choice for daily management. Packaged in a 10-tablet supply, Vogli is ideal for short-term relief or as part of an ongoing treatment plan. By targeting the underlying causes of vestibular symptoms, Vogli helps improve overall quality of life for individuals dealing with these inner ear conditions.
Active Ingredient: Contains 0.2 mg of Betahistine dihydrochloride, used for managing symptoms of vestibular disorders and Meniere's disease. Symptom Relief: Effective in alleviating symptoms such as dizziness, vertigo, and tinnitus associated with inner ear conditions. Enhances Blood Flow: Works by improving blood circulation in the inner ear, helping to stabilize symptoms related to inner ear pressure and function. Tablet Form: Comes in an easy-to-swallow tablet form, ensuring convenient and precise dosing. 10-Tablet Pack: Available in a pack of 10 tablets, suitable for short-term management or as part of a prescribed treatment regimen.
VOGLI 0.2MG TABLET works by blocking intestinal enzymes that break down complex sugars into simple sugars like glucose. This helps prevent a sharp rise in blood glucose levels immediately after meals.
Take VOGLI 0.2MG TABLET as directed by your physician. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition. Continue taking VOGLI 0.2MG TABLET for the prescribed duration to achieve the best results. For Tablets: Swallow VOGLI 0.2MG TABLET with a glass of water; do not crush or chew. For Dispersible Tablets: Dissolve VOGLI 0.2MG TABLET in the amount of water specified on the label or as directed by your doctor. Consume the solution immediately after preparation.
PREGNANCY RISKY: VOGLI 0.2MG TABLET should be used during pregnancy only if the potential benefits outweigh the risks to the fetus. Consult your doctor before taking it. BREASTFEEDING CONTRAINDICATED: VOGLI 0.2MG TABLET is generally not recommended for breastfeeding women, as it may pass into breast milk. Consult your doctor before taking it. KIDNEY USE WITH CAUTION: VOGLI 0.2MG TABLET should be used cautiously in patients with kidney issues. Consult your doctor for guidance. LIVER USE WITH CAUTION: VOGLI 0.2MG TABLET should be used cautiously in patients with liver problems. Consult your doctor for advice. ALLERGY CONTRAINDICATED: Do not take VOGLI 0.2MG TABLET if you are allergic to Voglibose or any of its ingredients. USE IN PEDIATRICS CONSULT YOUR DOCTOR: The safety of VOGLI 0.2MG TABLET in children has not been established. Consult your physician before use. USE IN GERIATRICS USE WITH CAUTION: VOGLI 0.2MG TABLET should be used with caution in elderly patients. Consult your physician before use.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s